Swedish Orphan Biovitrum AB
-
Ticker
Exchange
-
Industry
Drug Manufacturers - Major More
-
Sector
Healthcare More
- 1001-5000 Employees
- Based in Solna, Sweden
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic
…More lymphohistiocytosis(HLH); Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. The company It also provides other products, such as Akynzeo, Aloxi, Ammonul, Betapred, Caphosol, Fibclot, IVheBex, and Willfact. In addition, it develops drug substance for ReFacto AF/Xyntha for Pfizer; BIVV001 for haemophilia A; and Nirsevimab for respiratory syncytial virus. The company has a strategic collaboration with Apellis Pharmaceuticals Inc. to develop pegcetacoplan for the treatment of multiple rare diseases, including paroxysmal nocturnal hemoglobinuria. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.
REPORT RATINGS
5.0 / 5.0 (1)
Swedish Orphan Biovitrum AB reports have an aggregate usefulness score of 5.0 based on 1 reviews.
Swedish Orphan Biovitrum AB
Most Recent Responsibility Report
MOST RECENT
2023 Responsibility Report
Report Locked. Swedish Orphan Biovitrum AB has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Swedish Orphan Biovitrum AB Sustainability Report, Swedish Orphan Biovitrum AB Corporate Social Responsibility Report, Swedish Orphan Biovitrum AB CSR Report, Swedish Orphan Biovitrum AB Corporate Responsibility, Swedish Orphan Biovitrum AB CR Report, Swedish Orphan Biovitrum AB Citizenship Report, Swedish Orphan Biovitrum AB ESG Report, and Swedish Orphan Biovitrum AB Environmental Report online.